<DOC>
	<DOCNO>NCT02636868</DOCNO>
	<brief_summary>The primary objective study evaluate safety efficacy lucinactant inhalation administer aerosolize dose two dos preterm neonates 26 - 32 week gestational age receive nasal continuous positive airway pressure ( nCPAP ) Resipiratory Distress Syndrome ( RDS ) compare neonate receive nCPAP alone .</brief_summary>
	<brief_title>Trial Assess Safety Efficacy Lucinactant Inhalation Premature Neonates 26 32 Weeks Gestational Age</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<criteria>1 . Signed ICF legally authorize representative 2 . 26 0/7 32 6/7 complete week gestation PMA 3 . Successful implementation noninvasive support ventilation within 90 minute birth 4 . Spontaneous breathe 5 . Chest radiograph consistent RDS 6 . Within first 20 hour birth require nCPAP 5 7 cm H2O FiO2 â‰¥ 0.25 ( &gt; 0.21 neonate 2628 week PMA ) 0.40 clinically indicate least 30 minute maintain SpO2 90 % 95 % . Transient ( &lt; 10 minute ) FiO2 excursion outside range reset 30minute requirement . 1 . A heart rate stabilize 100 beat per minute ( bpm ) within 5 minute birth 2 . Recurrent episodes apnea require positive pressure ventilation ( PPV ) administer manually mechanically patient interface 3 . A 5 minute Apgar score &lt; 5 4 . Major congenital malformation ( ) craniofacial abnormality preclude use nCPAP , diagnose antenatally immediately birth 5 . Clinically significant disease condition RDS could potentially interfere cardiopulmonary function ( e.g . congenital heart disease , hydrops fetalis congenital infection ) 6 . A know suspect chromosomal abnormality syndrome 7 . Premature rupture membrane ( PROM ) &gt; 3 week 8 . Hemodynamic instability require vasopressor steroid hemodynamic support and/or presume clinical sepsis 9 . A need intubation and/or mechanical ventilation time enrollment study 10 . The administration ( plan administration ) follow : Another investigational agent investigational medical device Any surfactant agent Systemic corticosteroid ( antenatal steroid already receive ) 11 . Presence air leak ( pneumothorax , pneumomediastinum , pneumopericardium , subcutaneous emphysema , definite evidence pulmonary interstitial emphysema [ PIE ] ) baseline chest radiograph</criteria>
	<gender>All</gender>
	<minimum_age>26 Weeks</minimum_age>
	<maximum_age>32 Weeks</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>